SOLUBILIZATION OF HIGH-AFFINITY DOPAMINE RECEPTORS
SOLUBILIZATION OF HIGH-AFFINITY DOPAMINE RECEPTORS
复制标题
DOI:
10.1038/279072a0
复制
发表时间:
1979-01-01
期刊:
影响因子:
64.8
通讯作者:
LADURON, P
中科院分区:
文献类型:
--
作者:
GORISSEN, H;LADURON, P
NEUROLEPTIC drugs are thought to act by blocking brain dopamine receptors1.In vitrobinding assays using either3H-haloperidol2,3or3H-spiperone4,5have provided more direct evidence of this interaction. Although spiperone has been reported to label serotonergic receptors in the frontal cortex6, in the rat striatum, in bothin vitro4–9andin vivoconditions5,10,11, the binding characteristics of this drug are dopaminergic. Initial attempts to solubilise the neuroleptic receptor were recently undertaken in our laboratory, but the3H-spiperone macromolecular complex obtained from rat striatal membranes after digitonin treatment12did not show the original highaffinity binding characteristics for dopamine agonists and antagonists except for spiperone itself. More recently, solubilised neuroleptic sites were found in digitonin extracts from calf caudate but they were still not characterised13. We now report the solubilisation of binding sites from dog striatum which retain the characteristics of membrane-bound dopamine receptors.